You are here: Industry Insights > Merck

News List

Seattle Genetics and Merck Partner contractpharma
September 15, 2020
Seattle Genetics Inc. and Merck, known as MSD outside the United States and Canada, have announced two new strategic oncology collaborations.
Merck's Steglatro shows limited promise with heart failure hospitalization data fiercepharma
September 01, 2020
Late to the party against its SGLT2 diabetes rivals, Merck & Co.'s Steglatro has also tracked way behind in the class' growing presence in heart failure.
Merck files petition in US court against Aurobindo Pharma for Janumet expresspharma
August 27, 2020
In June, Merck had filed a petition against Dr Reddy's Laboratories in a US court over similar patent issues on Janumet and Januvia.
Sutro Biopharma Achieves Merck KGaA Clinical Supply Milestone contractpharma
August 26, 2020
Delivers GMP clinical trial supply to Merck KGaA for Phase 1 trial of M1231, a bispecific ADC for the treatment of solid tumors.
Merck to establish $1.3bn research hub in London pharmaceutical-technology
August 20, 2020
US-based pharmaceutical company Merck, known as MSD in Europe, is set to build a $1.3bn (£1bn) research hub on a 25,000m2 site in London, England, UK.
Merck licences NASH drug efinopegdutide from Hanmi pharmaceutical-technology
August 05, 2020
Merck (MSD) has signed an exclusive licensing agreement with Hanmi Pharmaceutical to develop, manufacture and commercialise efinopegdutide (formerly HM12525A) to treat nonalcoholic steatohepatitis (NASH).
Hackensack Meridian CDI, Merck Announce COVID-19 Research Collaboration americanpharmaceuticalreview
July 23, 2020
The Hackensack Meridian Center for Discovery and Innovation (CDI) has announced a research collaboration with Merck to investigate drugs for treating COVID-19.
Merck, contract research firm IRBM partner on coronavirus therapies pharmaceutical-technology
July 22, 2020
Merck (MSD) has collaborated with contract research services company IRBM for the identification and development of new peptide therapeutics that can target various strains of coronavirus, including SARS-CoV-2.
Rakuten Medical Closes Deal with Merck KGaA, Darmstadt, Germany americanpharmaceuticalreview
July 16, 2020
Rakuten Medical announced they have entered a multi-year deal with Merck KGaA, Darmstadt, Germany under which Merck KGaA, Darmstadt, Germany will provide cetuximab to Rakuten Medical for its ASP-1929 program.
Hackensack Meridian partners with Merck for Covid-19 research pharmaceutical-technology
July 16, 2020
The Hackensack Meridian Center for Discovery and Innovation (CDI) has entered into a research alliance with Merck to explore drugs for the treatment of Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page